Haven will aim to be an “advocate for the patient and an ally to anyone,” and will look to improve the healthcare system by improving access to care, aiding in navigation through the system and making medical treatments and prescription drugs more affordable.
Boston-based Haven’s initial focus will be on the 1.2 million employees that work under the three enterprises, according to a press release, but plans to “share what it learns to help others.”
“We want to change the way people experience health care so that it is simpler, better, and lower cost. We’ll start small, learn from the experience of patients, and continue to expand to meet their needs. The good news is the best results are not the most complicated or expensive. The right care in the right place is often more effective and less costly than what we get today,” CEO Dr. Atul Gawande said in a prepared statement.
Joining CEO Gawande are COO Jack Stoddard, CTO Serkan Kutan and measurement head Dana Safran, according to the press release.
Last month, a U.S. Federal Judge rejected a motion seeking to block a former Optum VP from joining Haven.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.